title: [Autologous dendritic cells eliciting cytotoxicity of bone marrow cells against chronic granulocytic leukemia].
abstract: OBJECTIVE
  To investigate the activity of bone marrow cells activated by autologous dendritic cells (DC) to mediate cytotoxicity against chronic granulocytic leukemia (CGL) cells.
  
  
  METHODS
  DC were separated from bone marrow mononuclear cells (BMMNC) of two CGL patients in hematological remission and harvested after 3 days of culture in IMDM containing autologous plasma, rhGM-CSF and rhTNFalpha at 37 degrees C, 5% CO(2) humidified atmosphere. BMMNC obtained from the patients were divided into 3 groups to set up Dexter systems: the control group, rhIL-2 containing, and the third group having DC added at day 4. After 10 days of culture, non-adherent cells were harvested and the changes of immunological phenotype and the percentage of P210 positive cells were analyzed. The cytotoxicity were assayed with two-colour flow cytometry. The non-adherent cells from all the 3 systems served as effector cells, those from control system as target cells.
  
  
  RESULTS
  The cytotoxic activity against target cells was greater in the DC-activated effector cells than that in rhIL-2-activated ones. The percentages of death cells in target cells were 63.12% versus 42.59% (case 1) and 61.60% versus 21.46% (case 2), respectively. In addition, there was a marked increase in the death cell percentage in the DC-activated effector cells themselves after incubation with target cells. This phenomenon was not found in the rhIL-2-activated effector cells. The percentage of P210 positive cells was significantly lower in non-adherent cells after 10 days of culture in Dexter system, comparing with that in non-cultured BMMNC. The least P210 positive cells were found in those cultured with DC and the less in those with rhIL-2.
  
  
  CONCLUSIONS
  Autologous DC were able to activate bone marrow cells to generate cytotoxicity against CGL cells. Their effect was greater than that of rhIL-2. These activated bone marrow cells might mediate graft versus leukemia effect in vivo.
authors.affiliation: Fujian Institute of Hematology, Union Hospital of Fujian Medical University, Fuzhou 350001, China.
authors.forename: J
authors.initials: J
authors.lastname: Chen
authors.forename: Z
authors.initials: Z
authors.lastname: Chen
authors.forename: X
authors.initials: X
authors.lastname: Wei
authors.forename: C
authors.initials: C
authors.lastname: Zhang
mesh_terms: D001854:Bone Marrow Cells / Q000276:immunology*; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic; D003713:Dendritic Cells / Q000276:immunology*; D006801:Humans; D007951:Leukemia, Myeloid / Q000276:immunology*; D007963:Leukocytes, Mononuclear / Q000276:immunology; D008297:Male; D008875:Middle Aged